Arcutis Biotherapeutics, Inc. announced that Officer Todd Franklin Watanabe plans to sell 15,000 shares of common stock on 12/20/2024. The aggregate market value of the shares to be sold is $227,567.The shares to be sold were acquired through multiple Restricted Stock Vesting transactions between 02/27/2023 and 03/03/2024, totaling 15,000 shares from Arcutis Biotherapeutics Inc. This planned sale follows a recent transaction where Watanabe sold 13,871 shares on 11/04/2024 for gross proceeds of $120,039.The notice for this planned sale was dated 12/20/2024, with the plan adoption or instruction given on 06/14/2024. This transaction represents a continuation of the officer's stock selling activities, potentially for portfolio management or personal financial planning purposes.

Arcutis Biotherapeutics, Inc. announced that Officer Todd Franklin Watanabe plans to sell 15,000 shares of common stock on 12/20/2024. The aggregate market value of the shares to be sold is $227,567.The shares to be sold were acquired through multiple Restricted Stock Vesting transactions between 02/27/2023 and 03/03/2024, totaling 15,000 shares from Arcutis Biotherapeutics Inc. This planned sale follows a recent transaction where Watanabe sold 13,871 shares on 11/04/2024 for gross proceeds of $120,039.The notice for this planned sale was dated 12/20/2024, with the plan adoption or instruction given on 06/14/2024. This transaction represents a continuation of the officer's stock selling activities, potentially for portfolio management or personal financial planning purposes.